Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Tai Jun Kim, Sohyun Kang, Jin Wook Jeoung, Young Kook Kim, Ki Ho Park

ABSTRACT

BACKGROUND: Many studies have investigated the clinical benefits of Ologen for trabeculectomy. However, its benefits for Ahmed glaucoma valve (AGV) implantation have not been investigated as extensively. The aim of this study was to compare the 1-year outcomes of AGV implantation with and without Ologen adjuvant for the treatment of refractory glaucoma. METHODS: This retrospective study included a total of 20 eyes of 20 glaucoma patients, who were followed for at least 1-year after undergoing AGV implantation. In 12 eyes of 12 patients, conventional AGV (CAGV) surgery was performed, while in 8 eyes of 8 patients, Ologen-augmented AGV (OAGV) implantation was performed. The outcomes were evaluated according to intraocular pressure (IOP) and the number of IOP-lowering medications. Complete success was defined as IOP ≤ 21 mmHg without medications throughout the 1-year follow-up period, and qualified success was defined as IOP ≤ 21 mmHg with or without medications throughout the 1-year follow-up period. RESULTS: The rate of complete success was significantly higher in the OAGV group (50.0%) than in the CAGV group (8.3%) (p = 0.035). There were no significant differences between the two groups in terms of qualified success or incidence of the early hypertensive phase. The IOP changes were similar between the groups within 1-year postoperatively, though the number of IOP-lowering medications was significantly lower in the OAGV group during the early hypertensive phase (p = 0.031, 0.031, and 0.025 at postoperative months 1, 2, and 3, respectively). When subjects were divided into groups according to the occurrence of the early hypertensive phase, the group with early hypertensive phase was more likely to use IOP-lowering medications at postoperative 6 months and 1 year (p = 0.002 and 0.005, respectively). CONCLUSIONS: OAGV surgery shows encouraging results for patients with refractory glaucoma, specifically with respect to the achievement of complete success and the reduction of the number of IOP-lowering medications during the early hypertensive phase. Furthermore, our results suggest that occurrence of the early hypertensive phase is predictive of which patients will require IOP-lowering medications at postoperative 6 months and 1 year. More... »

PAGES

45

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12886-018-0709-2

DOI

http://dx.doi.org/10.1186/s12886-018-0709-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1101042130

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29444665


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Collagen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glaucoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glaucoma Drainage Implants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycosaminoglycans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intraocular Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Implantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Visual Acuity", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Tai Jun", 
        "id": "sg:person.0624545604.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624545604.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rochester Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412750.5", 
          "name": [
            "University of Rochester Medical Center, Rochester, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Sohyun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeoung", 
        "givenName": "Jin Wook", 
        "id": "sg:person.01165265652.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165265652.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Young Kook", 
        "id": "sg:person.01341123542.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341123542.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Ki Ho", 
        "id": "sg:person.01233401052.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401052.25"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0161-6420(98)99042-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001833691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(98)99042-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001833691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0085782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002296695"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(14)72225-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005127692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ijg.0000000000000366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008836494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ijg.0000000000000366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008836494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ijg.0000000000000366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008836494"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.15-17480", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010265278"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2011.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011618438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(03)00630-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012634189"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ijg.0000000000000147", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014520947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/ijg.0000000000000147", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014520947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.1990.54", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017535983", 
          "https://doi.org/10.1038/eye.1990.54"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.1990.54", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017535983", 
          "https://doi.org/10.1038/eye.1990.54"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2014.03.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017918356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9394(14)73755-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024944578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(00)00391-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031775643"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ophtha.2010.07.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039652655"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0161-6420(95)30937-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040180638"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ajo.2011.10.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043433263"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.1988.138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045642934", 
          "https://doi.org/10.1038/eye.1988.138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/eye.1988.138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045642934", 
          "https://doi.org/10.1038/eye.1988.138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00417-002-0621-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048816220", 
          "https://doi.org/10.1007/s00417-002-0621-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/jop.2012.0120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059285164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075030481", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/opth.s104220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083890021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-017-0503-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084035064", 
          "https://doi.org/10.1007/s12325-017-0503-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-017-0503-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084035064", 
          "https://doi.org/10.1007/s12325-017-0503-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1167/iovs.17-22579", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092303817"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Many studies have investigated the clinical benefits of Ologen for trabeculectomy. However, its benefits for Ahmed glaucoma valve (AGV) implantation have not been investigated as extensively. The aim of this study was to compare the 1-year outcomes of AGV implantation with and without Ologen adjuvant for the treatment of refractory glaucoma.\nMETHODS: This retrospective study included a total of 20 eyes of 20 glaucoma patients, who were followed for at least 1-year after undergoing AGV implantation. In 12 eyes of 12 patients, conventional AGV (CAGV) surgery was performed, while in 8 eyes of 8 patients, Ologen-augmented AGV (OAGV) implantation was performed. The outcomes were evaluated according to intraocular pressure (IOP) and the number of IOP-lowering medications. Complete success was defined as IOP\u2009\u2264\u200921\u00a0mmHg without medications throughout the 1-year follow-up period, and qualified success was defined as IOP\u2009\u2264\u200921\u00a0mmHg with or without medications throughout the 1-year follow-up period.\nRESULTS: The rate of complete success was significantly higher in the OAGV group (50.0%) than in the CAGV group (8.3%) (p\u2009=\u20090.035). There were no significant differences between the two groups in terms of qualified success or incidence of the early hypertensive phase. The IOP changes were similar between the groups within 1-year postoperatively, though the number of IOP-lowering medications was significantly lower in the OAGV group during the early hypertensive phase (p\u2009=\u20090.031, 0.031, and 0.025 at postoperative months 1, 2, and 3, respectively). When subjects were divided into groups according to the occurrence of the early hypertensive phase, the group with early hypertensive phase was more likely to use IOP-lowering medications at postoperative 6\u00a0months and 1\u00a0year (p\u2009=\u20090.002 and 0.005, respectively).\nCONCLUSIONS: OAGV surgery shows encouraging results for patients with refractory glaucoma, specifically with respect to the achievement of complete success and the reduction of the number of IOP-lowering medications during the early hypertensive phase. Furthermore, our results suggest that occurrence of the early hypertensive phase is predictive of which patients will require IOP-lowering medications at postoperative 6\u00a0months and 1\u00a0year.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12886-018-0709-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024634", 
        "issn": [
          "1471-2415"
        ], 
        "name": "BMC Ophthalmology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "name": "Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant", 
    "pagination": "45", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c1e17a4685f2b44087af93a17d2c86b42800664ee6aa451e89b0648aedb844ae"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29444665"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967802"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12886-018-0709-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1101042130"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12886-018-0709-2", 
      "https://app.dimensions.ai/details/publication/pub.1101042130"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000552.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186/s12886-018-0709-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12886-018-0709-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12886-018-0709-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12886-018-0709-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12886-018-0709-2'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      21 PREDICATES      67 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12886-018-0709-2 schema:about N06daccf3386548a89fbc35fe4c849eae
2 N0831a4ab8b2f427793a9006b4ec915c2
3 N1ca33639f7ff4fffaba5f34de22ba2ae
4 N229f84d7224a4ef5b6909f49d1402e6e
5 N420df08c27964000a5e0abc94411d230
6 N496f61ce2ec740e48eec788ef2722b37
7 N560cd7383b88404d9bce5441a731a0ec
8 N6301e73c18f04ac5b9be153ad9462bd1
9 N8edea5adb9d7452e95b25404dfb37ff3
10 N8fee4ad6b28d4e799ef53800fabab623
11 Na0c051e20f9e414d8e357a4c01f64f73
12 Nbbe3fc66e6144eaf90135c7484f41eb3
13 Nc4487ac81f8547619ef54d29aee3a600
14 Ne1e0a4aab09a4fdeb3b38c291281d64e
15 Nf19e6769a30744ff93cc38d61eee513f
16 Nfe10eebbb6bb47339e64df3695d96983
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N533010816e8a4b12a74246802cf3830e
20 schema:citation sg:pub.10.1007/s00417-002-0621-5
21 sg:pub.10.1007/s12325-017-0503-1
22 sg:pub.10.1038/eye.1988.138
23 sg:pub.10.1038/eye.1990.54
24 https://app.dimensions.ai/details/publication/pub.1075030481
25 https://doi.org/10.1016/j.ajo.2011.10.024
26 https://doi.org/10.1016/j.ajo.2011.10.026
27 https://doi.org/10.1016/j.ophtha.2010.07.016
28 https://doi.org/10.1016/j.ophtha.2014.03.014
29 https://doi.org/10.1016/s0002-9394(03)00630-5
30 https://doi.org/10.1016/s0002-9394(14)72225-1
31 https://doi.org/10.1016/s0002-9394(14)73755-9
32 https://doi.org/10.1016/s0161-6420(00)00391-2
33 https://doi.org/10.1016/s0161-6420(95)30937-2
34 https://doi.org/10.1016/s0161-6420(98)99042-x
35 https://doi.org/10.1089/jop.2012.0120
36 https://doi.org/10.1097/ijg.0000000000000147
37 https://doi.org/10.1097/ijg.0000000000000366
38 https://doi.org/10.1167/iovs.15-17480
39 https://doi.org/10.1167/iovs.17-22579
40 https://doi.org/10.1371/journal.pone.0085782
41 https://doi.org/10.2147/opth.s104220
42 schema:datePublished 2018-12
43 schema:datePublishedReg 2018-12-01
44 schema:description BACKGROUND: Many studies have investigated the clinical benefits of Ologen for trabeculectomy. However, its benefits for Ahmed glaucoma valve (AGV) implantation have not been investigated as extensively. The aim of this study was to compare the 1-year outcomes of AGV implantation with and without Ologen adjuvant for the treatment of refractory glaucoma. METHODS: This retrospective study included a total of 20 eyes of 20 glaucoma patients, who were followed for at least 1-year after undergoing AGV implantation. In 12 eyes of 12 patients, conventional AGV (CAGV) surgery was performed, while in 8 eyes of 8 patients, Ologen-augmented AGV (OAGV) implantation was performed. The outcomes were evaluated according to intraocular pressure (IOP) and the number of IOP-lowering medications. Complete success was defined as IOP ≤ 21 mmHg without medications throughout the 1-year follow-up period, and qualified success was defined as IOP ≤ 21 mmHg with or without medications throughout the 1-year follow-up period. RESULTS: The rate of complete success was significantly higher in the OAGV group (50.0%) than in the CAGV group (8.3%) (p = 0.035). There were no significant differences between the two groups in terms of qualified success or incidence of the early hypertensive phase. The IOP changes were similar between the groups within 1-year postoperatively, though the number of IOP-lowering medications was significantly lower in the OAGV group during the early hypertensive phase (p = 0.031, 0.031, and 0.025 at postoperative months 1, 2, and 3, respectively). When subjects were divided into groups according to the occurrence of the early hypertensive phase, the group with early hypertensive phase was more likely to use IOP-lowering medications at postoperative 6 months and 1 year (p = 0.002 and 0.005, respectively). CONCLUSIONS: OAGV surgery shows encouraging results for patients with refractory glaucoma, specifically with respect to the achievement of complete success and the reduction of the number of IOP-lowering medications during the early hypertensive phase. Furthermore, our results suggest that occurrence of the early hypertensive phase is predictive of which patients will require IOP-lowering medications at postoperative 6 months and 1 year.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree true
48 schema:isPartOf N0ebccade0ec14a9c9b0fa1ad9fefd6b0
49 N8a4241da9d874f4db3c397ad96f2769f
50 sg:journal.1024634
51 schema:name Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant
52 schema:pagination 45
53 schema:productId N2246a580bc4843a685e4085e805aa000
54 N3f500f6f0a49419bae38b2b447b7d9c4
55 N532cd25899cc4787876a0e6d2e27d43e
56 N6bef1962fb1342dfb3bd0bf425199b14
57 Ndad0b384e30e458eb5e7ea2f1d0e49a1
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101042130
59 https://doi.org/10.1186/s12886-018-0709-2
60 schema:sdDatePublished 2019-04-10T15:08
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher N4976a553157346e1b03bfe2077eac810
63 schema:url http://link.springer.com/10.1186/s12886-018-0709-2
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N06daccf3386548a89fbc35fe4c849eae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Female
69 rdf:type schema:DefinedTerm
70 N0831a4ab8b2f427793a9006b4ec915c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Male
72 rdf:type schema:DefinedTerm
73 N0ebccade0ec14a9c9b0fa1ad9fefd6b0 schema:volumeNumber 18
74 rdf:type schema:PublicationVolume
75 N1329263f43404d45bde428641a1a28b8 rdf:first sg:person.01233401052.25
76 rdf:rest rdf:nil
77 N1ca33639f7ff4fffaba5f34de22ba2ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Prosthesis Implantation
79 rdf:type schema:DefinedTerm
80 N2246a580bc4843a685e4085e805aa000 schema:name nlm_unique_id
81 schema:value 100967802
82 rdf:type schema:PropertyValue
83 N229f84d7224a4ef5b6909f49d1402e6e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Follow-Up Studies
85 rdf:type schema:DefinedTerm
86 N2ffd3078177547029741562bd1ef522f schema:name Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea
87 rdf:type schema:Organization
88 N3d796cdca30240a1af560f661f4ef360 schema:affiliation https://www.grid.ac/institutes/grid.412750.5
89 schema:familyName Kang
90 schema:givenName Sohyun
91 rdf:type schema:Person
92 N3f500f6f0a49419bae38b2b447b7d9c4 schema:name dimensions_id
93 schema:value pub.1101042130
94 rdf:type schema:PropertyValue
95 N420df08c27964000a5e0abc94411d230 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Glycosaminoglycans
97 rdf:type schema:DefinedTerm
98 N496f61ce2ec740e48eec788ef2722b37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Middle Aged
100 rdf:type schema:DefinedTerm
101 N4976a553157346e1b03bfe2077eac810 schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N532cd25899cc4787876a0e6d2e27d43e schema:name pubmed_id
104 schema:value 29444665
105 rdf:type schema:PropertyValue
106 N533010816e8a4b12a74246802cf3830e rdf:first sg:person.0624545604.11
107 rdf:rest Nae015f8ac6a1471e9236749e94f5458c
108 N560cd7383b88404d9bce5441a731a0ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Glaucoma Drainage Implants
110 rdf:type schema:DefinedTerm
111 N6301e73c18f04ac5b9be153ad9462bd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Antihypertensive Agents
113 rdf:type schema:DefinedTerm
114 N6bef1962fb1342dfb3bd0bf425199b14 schema:name readcube_id
115 schema:value c1e17a4685f2b44087af93a17d2c86b42800664ee6aa451e89b0648aedb844ae
116 rdf:type schema:PropertyValue
117 N7c69a40d11874b2783b67695164d7c90 rdf:first sg:person.01341123542.67
118 rdf:rest N1329263f43404d45bde428641a1a28b8
119 N8a4241da9d874f4db3c397ad96f2769f schema:issueNumber 1
120 rdf:type schema:PublicationIssue
121 N8edea5adb9d7452e95b25404dfb37ff3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Visual Acuity
123 rdf:type schema:DefinedTerm
124 N8fee4ad6b28d4e799ef53800fabab623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Adult
126 rdf:type schema:DefinedTerm
127 N937648371dd14dfdb1bf88465a0649c6 rdf:first sg:person.01165265652.11
128 rdf:rest N7c69a40d11874b2783b67695164d7c90
129 N9794f85455db4c5b93a0bef78eaf0c0b schema:name Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea
130 rdf:type schema:Organization
131 Na0c051e20f9e414d8e357a4c01f64f73 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Retrospective Studies
133 rdf:type schema:DefinedTerm
134 Nae015f8ac6a1471e9236749e94f5458c rdf:first N3d796cdca30240a1af560f661f4ef360
135 rdf:rest N937648371dd14dfdb1bf88465a0649c6
136 Nbbe3fc66e6144eaf90135c7484f41eb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged
138 rdf:type schema:DefinedTerm
139 Nbd927c45a37c4ec3b7d17f6bd0fba9cd schema:name Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea
140 rdf:type schema:Organization
141 Nc4487ac81f8547619ef54d29aee3a600 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Intraocular Pressure
143 rdf:type schema:DefinedTerm
144 Ndad0b384e30e458eb5e7ea2f1d0e49a1 schema:name doi
145 schema:value 10.1186/s12886-018-0709-2
146 rdf:type schema:PropertyValue
147 Ne1e0a4aab09a4fdeb3b38c291281d64e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Glaucoma
149 rdf:type schema:DefinedTerm
150 Ne2538f711da0402fa4a37296611b08f3 schema:name Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro Jongno-gu, 03080, Seoul, Republic of Korea
151 rdf:type schema:Organization
152 Nf19e6769a30744ff93cc38d61eee513f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Humans
154 rdf:type schema:DefinedTerm
155 Nfe10eebbb6bb47339e64df3695d96983 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Collagen
157 rdf:type schema:DefinedTerm
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
162 schema:name Clinical Sciences
163 rdf:type schema:DefinedTerm
164 sg:journal.1024634 schema:issn 1471-2415
165 schema:name BMC Ophthalmology
166 rdf:type schema:Periodical
167 sg:person.01165265652.11 schema:affiliation Nbd927c45a37c4ec3b7d17f6bd0fba9cd
168 schema:familyName Jeoung
169 schema:givenName Jin Wook
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165265652.11
171 rdf:type schema:Person
172 sg:person.01233401052.25 schema:affiliation N2ffd3078177547029741562bd1ef522f
173 schema:familyName Park
174 schema:givenName Ki Ho
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401052.25
176 rdf:type schema:Person
177 sg:person.01341123542.67 schema:affiliation Ne2538f711da0402fa4a37296611b08f3
178 schema:familyName Kim
179 schema:givenName Young Kook
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341123542.67
181 rdf:type schema:Person
182 sg:person.0624545604.11 schema:affiliation N9794f85455db4c5b93a0bef78eaf0c0b
183 schema:familyName Kim
184 schema:givenName Tai Jun
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0624545604.11
186 rdf:type schema:Person
187 sg:pub.10.1007/s00417-002-0621-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048816220
188 https://doi.org/10.1007/s00417-002-0621-5
189 rdf:type schema:CreativeWork
190 sg:pub.10.1007/s12325-017-0503-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084035064
191 https://doi.org/10.1007/s12325-017-0503-1
192 rdf:type schema:CreativeWork
193 sg:pub.10.1038/eye.1988.138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045642934
194 https://doi.org/10.1038/eye.1988.138
195 rdf:type schema:CreativeWork
196 sg:pub.10.1038/eye.1990.54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017535983
197 https://doi.org/10.1038/eye.1990.54
198 rdf:type schema:CreativeWork
199 https://app.dimensions.ai/details/publication/pub.1075030481 schema:CreativeWork
200 https://doi.org/10.1016/j.ajo.2011.10.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043433263
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.ajo.2011.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011618438
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.ophtha.2010.07.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039652655
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/j.ophtha.2014.03.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017918356
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s0002-9394(03)00630-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012634189
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/s0002-9394(14)72225-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005127692
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/s0002-9394(14)73755-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024944578
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/s0161-6420(00)00391-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031775643
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/s0161-6420(95)30937-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040180638
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/s0161-6420(98)99042-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001833691
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1089/jop.2012.0120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059285164
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1097/ijg.0000000000000147 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014520947
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1097/ijg.0000000000000366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008836494
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1167/iovs.15-17480 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010265278
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1167/iovs.17-22579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092303817
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1371/journal.pone.0085782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002296695
231 rdf:type schema:CreativeWork
232 https://doi.org/10.2147/opth.s104220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083890021
233 rdf:type schema:CreativeWork
234 https://www.grid.ac/institutes/grid.412750.5 schema:alternateName University of Rochester Medical Center
235 schema:name University of Rochester Medical Center, Rochester, NY, USA
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...